Conference call replay (October 22th, 2018) ESMO 2018: Phase II trial of monalizumab and cetuximab
Innate Pharma - Converting science into the clinic
Interview of Mondher Mahjoubi, CEO, and Eric Vivier, CSO, in Biotech Strategy Blog.
(full article restricted to subscribers)
R&D Day Londres
Eric Vivier va combattre le cancer chez Innate Pharma
